Mayo Clinic Selected Topics in Glomerular Diseases and Kidney Pathology 2026
Glomerular Diseases 2026 | Nephrology | Renal Pathology | Kidney Biopsy | IgA Nephropathy | Mayo Clinic
Target Audience
Nephrologists, Renal Pathologists, Internal Medicine Physicians, Rheumatologists, Transplant Nephrologists, Physicians, Physician Assistants, Nurse Practitioners, Nurses, Nephrology Fellows, Internal Medicine Residents, Pathology Residents and Fellows, and healthcare professionals involved in the diagnosis and management of glomerular and kidney diseases.
Information
Mayo Clinic Selected Topics in Glomerular Diseases and Kidney Pathology 2026 is a specialized medical education program focusing on advances in glomerular disease diagnosis, renal pathology, kidney biopsy interpretation, and evidence-based nephrology management.
The original two-day course took place on October 2–3, 2026, under the direction of Fernando C. Fervenza, M.D., Ph.D.; Leticia Rolon, M.D.; and Ladan Zand, M.D.
The program integrates clinical nephrology, renal histopathology, serological investigations, genetic testing, and emerging therapeutic approaches to address complex kidney diseases.
Major educational topics include IgA nephropathy, lupus nephritis, membranoproliferative glomerulonephritis (MPGN), C3 glomerulonephritis, membranous nephropathy, renal vasculitis, and podocytopathies.
Additional sessions explore renal biopsy findings, fibrillary kidney pathology, antigen-based disease classification, mass spectrometry, and the clinical application of genetic testing in glomerular disorders.
The curriculum also addresses pregnancy-associated glomerular disease, paraprotein-related kidney disorders, thrombotic microangiopathy (TMA), and diabetic nephropathy.
Expert-led presentations, case-based discussions, and faculty Q&A sessions examine the integration of clinical findings, laboratory investigations, histopathological features, and therapeutic decision-making.
The digital educational package includes recorded video lectures and accompanying PDF materials, supporting flexible, independent review of the original two-day course.
Course Details
| Information | Details |
|---|---|
| Course Title | Selected Topics in Glomerular Diseases and Kidney Pathology |
| Organizer | Mayo Clinic |
| Edition | 2026 |
| Original Course Dates | October 2–3, 2026 |
| Duration | Two-Day Educational Program |
| Format | Recorded Video Lectures + PDF Materials |
| Included Materials | Videos + PDFs |
| Course Directors | Fernando C. Fervenza, M.D., Ph.D.; Leticia Rolon, M.D.; Ladan Zand, M.D. |
| Primary Specialty | Nephrology |
| Additional Focus | Renal Pathology, Glomerular Diseases, Internal Medicine |
| Language | English |
Learning Objectives
Upon completion of this educational activity, participants should be better able to:
- Apply evidence-based, patient-centered approaches to diagnosing and managing glomerular diseases.
- Integrate clinical, serological, genetic, and histopathological information into diagnostic decision-making.
- Evaluate emerging diagnostic methods and treatment approaches for immune-mediated and complement-mediated kidney disorders.
- Review management strategies for IgA nephropathy, lupus nephritis, and membranoproliferative glomerulonephritis.
- Understand advances in the classification and management of membranous nephropathy.
- Recognize important pathological features associated with podocytopathy and other glomerular disorders.
- Address challenges encountered in patients with glomerular diseases during pregnancy.
- Evaluate kidney disorders associated with monoclonal proteins and thrombotic microangiopathy.
- Review pathological characteristics and emerging treatment approaches in diabetic nephropathy.
- Apply clinical and pathological findings to challenging nephrology cases.
Complete Two-Day Course Program
Day 1 – October 2, 2026
Session I: IgA Nephropathy and Genetics
Moderator: Leticia Rolon, M.D.
What Should Our Approach Be When Managing a Patient with IgA Nephropathy?
Faculty: Ladan Zand, M.D.
Reviews clinical assessment, therapeutic considerations, and management approaches for patients with IgA nephropathy.
How to Manage Patients with IgA Nephropathy: Case-Based Discussion
Moderator: Ladan Zand, M.D.
Panelists: Richard J. Glassock, M.D., F.A.S.N.; Ali Poyan Mehr, M.D.; Fernando C. Fervenza, M.D., Ph.D.
Examines clinical cases involving IgA nephropathy, emphasizing diagnostic reasoning and therapeutic decision-making.
When Should We Consider Genetic Testing in Patients with Glomerular Diseases?
Faculty: Ann M. Moyer, M.D., Ph.D.
Explores the clinical role of genetic testing and patient selection in glomerular disease evaluation.
Session Q&A with the presenters
Session II: Lupus Nephritis
Moderator: Loren P. Herrera Hernandez, M.D.
Endpoints in Lupus Nephritis
Faculty: Fernando C. Fervenza, M.D., Ph.D.
Reviews clinical and research endpoints relevant to lupus nephritis assessment and treatment evaluation.
Lupus Management from a Rheumatologist Point of View
Faculty: Ali A. Duarte Garcia, M.D.
Discusses lupus management from a rheumatology perspective and its implications for renal disease.
Session Q&A with the presenters
Session III: MPGN and Fibrils
Moderator: Ali Poyan Mehr, M.D.
Treatment Options for Patients with C3GN and Immune Complex MPGN
Faculty: Carla M. Nester, M.D., M.S.A., F.A.S.N.
Reviews therapeutic approaches to C3 glomerulonephritis and immune complex-mediated membranoproliferative glomerulonephritis.
Pathology of MPGN: Case-Based Discussion
Faculty: Fernando C. Fervenza, M.D., Ph.D.; Sanjeev Sethi, M.D., Ph.D.; Carla M. Nester, M.D., M.S.A., F.A.S.N.; Richard J. Glassock, M.D., F.A.S.N.
Examines histopathological findings and clinicopathological correlation in MPGN through clinical cases.
How to Make Sense of Fibrils on Kidney Pathology
Faculty: Priya P. Alexander, M.D.
Reviews fibrillary findings in kidney pathology and their importance in diagnostic interpretation.
Session Q&A with the presenters
Session IV: Vasculitis
Moderator: Fernando C. Fervenza, M.D., Ph.D.
How to Treat Patients with ANCA Associated Vasculitis with Severe Renal Involvement
Faculty: Ulrich Specks, M.D.
Examines treatment considerations for ANCA-associated vasculitis with severe kidney involvement.
Cryoglobulin Vasculitis: Diagnosis and Management
Faculty: Dario Roccatello, M.D., Ph.D.
Reviews diagnostic approaches and management strategies for cryoglobulinemic vasculitis.
Challenging Cases of ANCA Associated Vasculitis and Cryoglobulinemic Glomerulonephritis
Faculty: Leticia Rolon, M.D.
Presents challenging clinical cases involving ANCA-associated vasculitis and cryoglobulinemic glomerulonephritis.
Session Q&A with the presenters
Day 2 – October 3, 2026
Session I: Membranous Nephropathy
Moderator: Andrea G. Kattah, M.D.
Role of Mass Spectrometry and Antigen-Based Approach in MN
Faculty: Sanjeev Sethi, M.D., Ph.D.
Explores antigen-based classification and mass spectrometry in the diagnosis of membranous nephropathy.
Advances in Management of Patients with MN
Faculty: Fernando C. Fervenza, M.D., Ph.D.
Reviews developments in the management of membranous nephropathy.
Case-Based Discussion on Management of Patients with MN
Moderator: Leticia Rolon, M.D.
Expert Panel: Fernando C. Fervenza, M.D., Ph.D.; Sanjeev Sethi, M.D., Ph.D.; Ladan Zand, M.D.; Ali Poyan Mehr, M.D.
Reviews clinical scenarios and practical therapeutic considerations in membranous nephropathy.
Session Q&A with the presenters
Session II: Podocytopathy
Moderator: Ladan Zand, M.D.
What is New in the Pathology and Pathogenesis of Podocytopathy
Faculty: Paola Romagnani, M.D., Ph.D.
Reviews evolving concepts in podocyte pathology and mechanisms underlying podocytopathies.
Treatment Approach to Patients with Primary Podocytopathy
Faculty: Richard J. Glassock, M.D., F.A.S.N.
Discusses treatment approaches to primary podocytopathy.
Session Q&A with the presenters
Session III: Pregnancy
Moderator: Leticia Rolon, M.D.
Pregnancy Discussion and Planning in Patients with Glomerular Diseases
Faculty: Andrea G. Kattah, M.D.
Examines pregnancy planning and management considerations for patients with glomerular diseases.
Glomerulonephritis in Pregnancy, Management Challenges and the Role of Kidney Biopsy
Faculty: Vesna D. Garovic, M.D., Ph.D.
Reviews clinical challenges involving glomerulonephritis during pregnancy and the role of kidney biopsy in selected cases.
Session Q&A with the presenters
Session IV: Paraproteins/TMA
Moderator: Mireille El Ters, M.D.
How do Monoclonal Proteins Impact the Kidney?
Faculty: Nelson Leung, M.D.
Reviews kidney disorders associated with monoclonal proteins and their clinical implications.
Thrombotic Microangiopathy and the Kidneys
Faculty: Meera Sridharan, M.D., Ph.D.
Examines thrombotic microangiopathy and its relationship to kidney injury.
Session Q&A with the presenters
Session V: Diabetic Nephropathy
Moderator: Ladan Zand, M.D.
Nephropathology of Diabetes and its Sweet Surprises
Faculty: Alessia Buglioni, M.D.
Reviews the histopathological characteristics and diagnostic findings associated with diabetic nephropathy.
Diabetic Nephrology in 2026: New Therapeutic Frontiers
Faculty: Aleksandra Kukla, M.D.
Explores emerging therapeutic developments and clinical management approaches in diabetic kidney disease.
Session Q&A with the presenters
Core Educational Topics
Glomerular Diseases
- IgA nephropathy
- Lupus nephritis
- Membranoproliferative glomerulonephritis
- C3 glomerulonephritis
- Immune complex-mediated kidney disease
- Membranous nephropathy
- Podocytopathies
Renal Pathology
- Kidney biopsy interpretation
- Glomerular histopathology
- Fibrillary pathology
- Antigen-based diagnostic classification
- Mass spectrometry applications
- Clinicopathological correlation
Renal Vasculitis
- ANCA-associated vasculitis
- Severe renal involvement
- Cryoglobulinemic vasculitis
- Cryoglobulinemic glomerulonephritis
- Clinical case evaluation
Special Clinical Populations
- Pregnancy and glomerular disease
- Glomerulonephritis during pregnancy
- Renal biopsy considerations
- Paraprotein-associated kidney disease
- Monoclonal protein disorders
Diabetic Kidney Disease
- Diabetic nephropathy
- Diabetic kidney pathology
- Emerging therapeutic approaches
- Clinical nephrology management
Educational Highlights
- Mayo Clinic Nephrology Education 2026
- Two-Day Recorded Course
- Video Lectures and PDF Materials
- IgA Nephropathy
- Lupus Nephritis
- C3 Glomerulonephritis
- Membranoproliferative Glomerulonephritis
- Membranous Nephropathy
- Kidney Biopsy Interpretation
- Renal Histopathology
- Genetic Testing
- Renal Vasculitis
- Podocytopathies
- Pregnancy-Related Glomerular Disease
- Paraprotein-Associated Kidney Disorders
- Thrombotic Microangiopathy
- Diabetic Nephropathy
- Expert-Led Clinical Case Discussions
Clinical & Educational Value
Mayo Clinic Selected Topics in Glomerular Diseases and Kidney Pathology 2026 provides an advanced educational review of glomerular disorders and renal pathology, combining clinical nephrology with diagnostic histopathology and emerging therapeutic approaches.
The course emphasizes the integration of clinical findings, renal biopsy results, serological investigations, genetic testing, and pathology interpretation when evaluating complex glomerular diseases.
Its educational curriculum covers important renal disorders, including immune-mediated and complement-mediated glomerulonephritis, podocytopathies, renal vasculitis, diabetic nephropathy, and paraprotein-related kidney disease.
Expert presentations and case-based discussions provide opportunities to review challenging diagnostic and therapeutic scenarios.
The recorded lectures and accompanying PDF materials support independent professional education for nephrologists, renal pathologists, internal medicine physicians, and nephrology trainees.
Educational Notice: Participation in or review of a Mayo Clinic educational activity does not guarantee clinical competence or proficiency in the medical knowledge, skills, or procedures discussed. This digital recording package does not imply official Mayo Clinic learning-platform access, CME credits, or certification.



